Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
January 27, 2011 1:34 PM 2 min read

P&G Reports Ahead of Estimates - Analyst Blog

by Web Master Benzinga Editor
Follow
PG Logo
PGProcter & Gamble Co
$160.100.02%
Overview

Procter & Gamble Co. (PG) reported modest results for its fiscal second quarter of 2011. Net earnings from continuing operations were $1.11 a share, up 10% compared with $1.01 a share in the year-ago period, surpassing the Zacks Consensus Estimate of $1.10.

Procter & Gamble forecasts third-quarter 2011 net earnings from continuing operations and core earnings to be in the range of $0.95 to $1.00 per share, reflecting a 7%–12% growth rate. The Zacks Consensus Estimate for the third quarter is 99 cents per share.

For fiscal 2011, the company forecasts its net earnings from continuing operations to be in the range of $3.89–$3.99 per share and core earnings to be in the range of $3.91–$4.01 per share. The guidance reflects an increase of 10%–13% based on continuing operations and up 7%–9% on a core basis. The Zacks Consensus Estimate for fiscal 2011 is $3.99.

Revenue and Margins

Net sales advanced marginally by 1.5% to $21.3 billion in the second-quarter of fiscal 2011. Quarterly revenues missed the Zacks Consensus Estimate of $21.5 billion. Excluding the impact of acquisitions, divestitures and foreign exchange, organic sales inched up 3% in the reported quarter.

On the back of a solid innovation program and marketing investment, the company reported unit volume growth throughout fiscal 2010. Quarterly volume grew 6%.

Procter & Gamble, the leading manufacturer and seller of consumer goods, projects net sales and organic sales (based on solid volume momentum, partially offset by product mix and pricing) to inflate by 5%–7% and 4%–6%, respectively, in the third quarter of 2011. For fiscal 2011, net sales and organic sales are expected to grow by 3%–5% and 4%–6%, respectively.

For the third quarter, net sales are expected to increase approximately 1% from favorable currency translation. For fiscal 2011, acquisitions and divestitures are expected to have a neutral impact on net sales, while unfavorable currency translation is expected to impact revenues by 1%–2%.

Gross margin for the quarter declined 190 basis points primarily attributable to higher commodity costs and unfavorable product mix. Operating margin contracted 210 basis points (bps) to 20.0%, compared with 22.1% in the year-ago quarter, primarily due to lower gross margin and a 20 bps increase in selling, general and administrative expenses (SG&A) as a percentage of net sales.

Other Financial Updates

Procter & Gamble exited the quarter with cash and cash equivalents of $3,249 million and long-term debt of $21,317 million. The company spent $1,256 million for capital expenditures.

The company continues to enhance shareholders' returns by spending $500 million on share repurchases.

Based in Cincinnati, Ohio, Procter & Gamble is one of the leading provider of consumer packaged goods in the United States and internationally. Procter & Gamble maintains a Zacks #3 Rank, which translates into a short-term "Hold" recommendation. However, our long-term recommendation for the stock remains "Neutral".



PROCTER & GAMBL (PG
): Free Stock Analysis Report


Zacks Investment Research
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Consumer StaplesHousehold Products
PG Logo
PGProcter & Gamble Co
$160.100.02%
Overview
Comments
Loading...